Statistics

Total Visits

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group10

Select a period of time:

Number of views in the range

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group5

Views

Views
November 20230
December 20231
January 20242
February 20240
March 20241
April 20241
May 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States4
Spain1
 

Top cities views

Views
Boardman2
Santiago de Compostela1